Indian equity benchmarks continued their upward momentum for the sixth consecutive session on Thursday, supported by sustained buying in pharma, banking, and energy stocks. The BSE Sensex closed 142.87 points higher at 82,000.71, while the NSE Nifty gained 33.20 points to settle at 25,083.75, crossing the psychological 25,050 mark for the first time this week.<\/p>\n\n\n\n
Despite mixed global cues and selective profit booking, domestic indices remained resilient. The rally was led by large-cap pharma stocks and private banks, while midcap and smallcap indices showed signs of fatigue after a strong three-day run.<\/p>\n\n\n\n
The India VIX, which measures market volatility, declined over 3 percent to 11.37, indicating a stable trading environment and reduced investor anxiety.<\/p>\n\n\n\n
Pharma stocks were the standout performers of the day. Cipla rose 3 percent, driven by strong quarterly earnings and positive sentiment around its product pipeline. Dr. Reddy\u2019s Laboratories gained 2 percent, supported by robust export demand and margin expansion.<\/p>\n\n\n\n
Other notable gainers included:<\/p>\n\n\n\n
These stocks benefited from institutional buying and favorable sectoral outlooks.<\/p>\n\n\n\n
Gaining Sectors:<\/strong><\/p>\n\n\n\n Declining Sectors:<\/strong><\/p>\n\n\n\n The divergence reflects a cautious approach by investors, with a preference for defensives and quality large-cap names.<\/p>\n\n\n\n SEBI Chairman Tuhin Kanta Pandey, speaking at the FICCI Capital Market Conference, hinted at extending the tenure of equity derivatives. This move, if implemented, could reshape trading strategies and risk management practices.<\/p>\n\n\n\n Meanwhile, the Group of Ministers approved the Centre\u2019s proposal for GST rate rationalisation, supporting a simplified two-slab structure. This reform is expected to boost consumption and improve compliance, particularly in the auto and consumer goods sectors.<\/p>\n\n\n\n Global markets remained mixed amid geopolitical tensions and commodity price fluctuations. However, Indian equities showed resilience, supported by strong domestic fundamentals and policy clarity.<\/p>\n\n\n\n Key factors to watch in the coming sessions include:<\/p>\n\n\n\n The sixth straight day of gains reflects investor confidence, but sectoral divergence and midcap weakness suggest a phase of consolidation. Pharma and private banks remain in favor, while auto and FMCG may face selective pressure until policy clarity improves.<\/p>\n\n\n\n With Nifty breaching 25,000 and Sensex holding above 82,000, the short-term trend remains positive. However, traders and investors are advised to stay cautious, manage risk, and rely on research-backed strategies\u2014especially from SEBI-registered analysts who offer regulated, data-driven insights.<\/p>\n\n\n\n Eqwires Research Analyst<\/a><\/strong><\/p>\n\n\n\n Top-notch SEBI registered research analyst<\/a><\/strong><\/p>\n\n\n\n Best SEBI registered Intraday tips provider <\/a><\/strong><\/p>\n\n\n\n info@eqwires.com<\/strong><\/a><\/p>\n\n\n\n Telegram <\/a>| Facebook <\/a>| Instagram<\/a><\/strong><\/p>\n\n\n\n Call: +91 9624421555 \/ +91 9624461555<\/em><\/strong><\/p>\n\n\n\n www.eqwires.com<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":" Indian equity benchmarks continued their upward momentum for the sixth consecutive session on Thursday, supported by sustained buying in pharma, banking, and energy stocks. The BSE Sensex closed 142.87 points higher at 82,000.71, while the NSE Nifty gained 33.20 points to settle at 25,083.75, crossing the psychological 25,050 mark for the first time this week. Market Overview: Strength Amid Sectoral Rotation Despite mixed global cues and selective profit booking, domestic indices remained resilient. The rally … Continue reading “Stock Market Highlights: Sensex Extends Winning Streak to 6 Days, Nifty Tops 25,050; Pharma Stocks Lead Gains”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":4930,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[74],"tags":[],"class_list":["post-4929","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-sebi-registered-advisory-company"],"_links":{"self":[{"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/posts\/4929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/comments?post=4929"}],"version-history":[{"count":1,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/posts\/4929\/revisions"}],"predecessor-version":[{"id":4931,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/posts\/4929\/revisions\/4931"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/media\/4930"}],"wp:attachment":[{"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/media?parent=4929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/categories?post=4929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eqwires.com\/tutorials\/wp-json\/wp\/v2\/tags?post=4929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n
Policy Developments: SEBI and GST in Focus<\/h3>\n\n\n\n
Global Cues and Market Outlook<\/h3>\n\n\n\n
\n
Conclusion: Momentum Intact, But Caution Advised<\/h3>\n\n\n\n